AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended beneficial ownership statement with the SEC on November 13, 2026, reporting aggregate ownership of 670,805 shares of Tonix Pharmaceuticals Holding Corp. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: AQR Capital Management, LLC and AQR Capital Management Holdings, LLC each reported beneficial ownership of 670,805 shares of Tonix Pharmaceuticals Holding Corp. common stock.
  • Percent of class: The 670,805 shares represent 3.91% of the outstanding class of common stock, according to the filing.
  • Shared voting power: Both reporting persons disclosed shared voting power over 662,862 shares, with sole voting power of 0.
  • Shared dispositive power: Both entities reported shared dispositive power over 670,805 shares, with sole dispositive power of 0.
  • Corporate relationship: The filing states that AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
  • Triggering event date: The date of the event requiring the filing was listed as September 30, 2026.
  • Amendment number: This filing is Amendment No. 1 to a prior statement.

AQR Capital's Reported Position in Tonix Pharmaceuticals as of September 30, 2026

According to the amended filing, AQR Capital Management, LLC, a U.S.-based investment adviser, and its parent AQR Capital Management Holdings, LLC, a U.S.-based holding company, together reported beneficial ownership of 670,805 shares of common stock in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a pharmaceutical company headquartered at 200 Connell Drive, Suite 3100, Berkeley Heights, New Jersey 07922. The filing identifies AQR Capital Management, LLC as the investment adviser entity and AQR Capital Management Holdings, LLC as the parent holding company, both organized under the laws of the United States and operating from One Greenwich Plaza, Suite 130, Greenwich, Connecticut 06830.

The filing discloses that neither reporting person holds any sole voting or sole dispositive power over the reported shares. Instead, shared voting power of 662,862 shares and shared dispositive power of 670,805 shares are attributed equally to both AQR Capital Management, LLC and AQR Capital Management Holdings, LLC. The filing certifies, in the words of the document, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Item 5 of the filing further notes that this represents ownership of 5 percent or less of the class.

The statement was signed by Henry Parkin as Authorized Signatory on behalf of both entities on November 13, 2026. An exhibit attached to the filing confirms the subsidiary relationship between AQR Capital Management, LLC and AQR Capital Management Holdings, LLC and states that the schedule is filed jointly on behalf of both parties.

What Was Disclosed

AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC filed Amendment No. 1 to a beneficial ownership statement covering 670,805 shares, or 3.91%, of Tonix Pharmaceuticals Holding Corp. common stock, with the triggering event dated September 30, 2026.